Ion Beam Applications SA
Pierre Mottet has extensive leadership experience in various organizations, currently serving as Chairman of the Board at IBA and TELEMIS, as well as Chairman at XYLERGY and Président of the Union Wallonne des Entreprises. Mottet has co-founded the initiative 2030 and founded the Foundation for Future Generations, focusing on sustainable entrepreneurship. With a background in business and engineering, Mottet held significant roles at invest.bw, including being a former Administrateur délégué, and contributed to Agoria for nearly two decades in multiple capacities. Mottet holds a Master of Business Administration (MBA) in Commercial Engineering from the Université catholique de Louvain.
This person is not in the org chart
This person is not in any teams
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.